Valeant Pharmaceuticals International Inc. CEO J. Michael Pearson has taken a medical leave of absence.
Company officials said he has been diagnosed with severe pneumonia.
In the interim, a three-person team will lead the drugmaker.
Read more from
The Wall Street Journal.